Quarterly report pursuant to Section 13 or 15(d)

Stock Based Compensation - Summary of Stock Option Activity Under Equity Incentive Plan (Detail)

v3.22.1
Stock Based Compensation - Summary of Stock Option Activity Under Equity Incentive Plan (Detail) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 12 Months Ended
Mar. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]      
Outstanding Options Number of Shares, Beginning Balance 7,854,473 6,697,927  
Number of Shares, Options granted 2,106,553 2,683,818  
Number of Shares, Options exercised 0 (320,716)  
Number of shares, Options cancelled (356,123) (1,206,556)  
Outstanding Options Number of Shares, Ending Balance 9,604,903 7,854,473 6,697,927
Outstanding Options Number of Shares, Vested and expected to vest, March 31, 2022 9,604,903    
Outstanding Options Number of Shares, Exercisable at March 31, 2022 4,709,331    
Weighted Average Exercise Price, Beginning Balance $ 10.21 $ 9.13  
Weighted Average Exercise Price, Options granted 2.76 12.84  
Weighted Average Exercise Price, Options exercised 0 5.05  
Weighted Average Exercise Price, Options cancelled 9.75 11.46  
Weighted Average Exercise Price, Ending Balance 8.59 $ 10.21 $ 9.13
Weighted Average Exercise Price, Vested and expected to vest, March 31, 2022 8.59    
Weighted Average Exercise Price, Exercisable at March 31, 2022 $ 8.94    
Weighted-Average Remaining Contractual Term, Outstanding 7 years 3 months 18 days 6 years 8 months 19 days 7 years 9 months 3 days
Weighted-Average Remaining Contractual Term, Vested and expected to vest, March 31, 2022 6 years 11 months 4 days    
Weighted-Average Remaining Contractual Term, Exercisable at March 31, 2022 5 years 11 months 4 days    
Aggregate Intrinsic Value, Outstanding $ 2,190 $ 950 $ 13,790
Aggregate Intrinsic Value, Vested and expected to vest, June 30, 2021 2,190    
Aggregate Intrinsic Value, Exercisable at June 30, 2021 $ 810